Altos Labs

From Wikipedia, the free encyclopedia

Altos Labs is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. The company was started in 2022.

History[]

The name Altos Labs is based on the city of Los Altos in California.[1] The idea for Altos Labs originated with cell biologist and entrepreneur Richard D. Klausner, who co-founded the company with . One of the early investors of Altos Labs is an investment vehicle held for the benefit of the Breakthrough Foundation, founded by Israeli science and technology investor and philanthropist Yuri Milner and his wife Julia. The foundation supports existing and future philanthropic projects in fundamental sciences. [2] Milner had previously shown interest in anti-aging technologies, in October 2020, he co-hosted a meeting where experts presented their research, reported on animal testing, and the concept for Altos Labs was developed. The company has been able to recruit prominent scientists such as Juan Carlos Izpisúa Belmonte (known for his work on rejuvenation through cell reprogramming), Steve Horvath (known for his work on the epigenetic aging clock), and Shinya Yamanaka (the Nobel Prize-winning inventor of cellular reprogramming in mammalian cells). The board of directors also includes well-known scientists such as Jennifer A. Doudna, David Baltimore, and Frances Arnold.[3] In the process, Altos Labs pays scientists salaries up to ten times higher than at comparable research institutions.[4] In 2021, Altos Labs was registered in the United States and the United Kingdom.[5]

Altos Labs raised $3 billion in a funding round from investors in January 2022.[5] Investors reportedly included Amazon founder Jeff Bezos.[6] Altos Labs plans to establish research facilities in Cambridge, the San Francisco Bay Area, and in San Diego as a first step.[3] Untypical of a private company, the initial focus will be on basic research without immediate prospects of a commercially viable product.[1]

External links[]

References[]

  1. ^ a b "A $3bn bet on finding the fountain of youth". The Economist. 2022-01-22. ISSN 0013-0613. Retrieved 2022-01-26.
  2. ^ "Jeff Bezos, Yuri Milner Said to Be Among Backers of Anti-Ageing Startup Altos Labs". gadgets360.com. Retrieved 2022-02-23.
  3. ^ a b "Altos Labs". altoslabs.com. Retrieved 2022-01-26.
  4. ^ "Altos Labs: Wie Jeff Bezos und Co. das Altern besiegen wollen". Heise.com (in German). Retrieved 2022-01-26.
  5. ^ a b "Meet Altos Labs, Silicon Valley's latest wild bet on living forever". MIT Technology Review. Retrieved 2022-01-26.
  6. ^ "Jeff Bezos has reportedly invested in anti-aging startup Altos Labs". New York Post. 2021-09-07. Retrieved 2022-01-26.
Retrieved from ""